COVID-19 Updates

Novavax cuts full-year revenue forecast again amid weak demand

Read more

Indian drug 2DG can reduce heart damage by coronavirus, find US researchers

Read more

50 million doses of Covaxin set to expire early 2023

Read more

Biological E’s Corbevax safe and immunogenic in five to 18 age group

Read more

Moderna COVID vaccine sales forecasts fall short for 2022, 2023

Read more

China rolls out first inhalable COVID vaccine

Read more

US government to test Pfizer’s Paxlovid for long COVID

Read more

Pfizer COVID vaccine price hike seen giving revenue boost for years

Read more

US FDA authorises Novavax’s COVID vaccine as booster for adults

Read more

SII stopped Covishield production in Decemeber 2021: Poonawalla

Read more